Abstract:Although accounting for only 10% of all Parkinson’s disease (PD) cases, familial forms have contributed substantially to our understanding of its molecular pathophysiology. Among known autosomal-recessive forms of PD, several genes have been implicated in mitophagy, the process of degradation of dysfunctional mitochondria. The activation of the E3 ubiquitin ligase parkin (PARK2 [mendelian inheritance in man (MIM):602544]) is dependent on phosphatase and tensin homolog-induced kinase 1 (PINK1 [MIM: 608309]) and eventually leads to the mitophagy of reactive oxygen species (ROS)-producing mitochondria. Mutation of parkin and PINK1 in turn lead to the accumulation of ROS and dysfunctional mitochondria and ultimately cell damage and degeneration. DJ-1 (MIM:602533), among other roles, acts as a transcription factor influencing autophagy and mitochondrial dysfunction. Recently, Lesage and colleagues described homozygous and compound heterozygous mutations in vacuolar protein sorting 13C (VPS13C [MIM:608879]) as another monogenic, autosomal recessive cause of PD. The authors used a combination of whole-genome homozygosity linkage mapping in patients with confirmed consanguinity (inbreeding coefficient F 61⁄4 0) and 10-30x whole-exome sequencing and comparison to more than 500 healthy controls for gene identification. Clinically, the 3 identified subjects presented with an asymmetric bradykinetic-rigid syndrome with initially preserved Levodopa response but aggressive degenerative course and early cognitive decline similar to other recessive forms of PD. Postmortem analysis of 1 case revealed combined Lewy body and TAU pathology. Subsequent cell culture experiments on human HEK293T and nonhuman primate COS-7 cells verified the location of VSP13C on the mitochondrial surface and demonstrated its influence on mitochondrial activity and maintenance as well as multiple interdependent loops between parkin, PINK1, and VPS13C in the regulation of mitophagy. The involvement of vacuolar protein sorting family proteins in vesicular trafficking suggests that VSP13C might be involved in peroxisomal transport. Observational and experimental data in animal models and humans on the effect of MPTP, rotenone, and paraquat has long suggested a causal relationship between complex I inhibition and PD. Similarly, axonal dystrophy in PLA2G6 has recently been attributed to mitochondrial dysfunction. Strengthened by prior genetic work in familial PD, the discovery of VPS13C continues a long line of evidence that links 2 fundamental cell functions in the pathophysiology of PD: energy metabolism and degradation of dysfunctional cell organelles. At the same time, it further strengthens the role of PINK1/parkin-dependent regulation of mitophagy.

DCTN1-related Parkinson-plus disorder (Perry syndrome)

A Chinese pedigree with Perry disease caused by the p.Y78H mutation in DCTN1 : A 6-year clinical follow-up

Perry Disease: Bench to Bedside Circulation and a Team Approach

DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation

Mortalin: A Protein Associated with Progression of Parkinson Disease?

The role of NOTCH2NLC in Parkinson's disease: A clinical, neuroimaging, and pathological study

Proteomic Identification Of A Stress Protein, Mortalin/Mthsp70/Grp75 - Relevance To Parkinson Disease

Analysis of Clinical Phenotype and CGH1 Gene Mutations in a Family Affected with Dopa-Responsive Dystonia

Pyruvate dehydrogenase-E1α deficiency presenting as generalized dystonia: a genetic diagnosis with important clinical implications.

Novel Missense Variant in the TMEM151A Gene Causing Paroxysmal Kinesigenic Dyskinesia: a Case Report with Literature Review

Early-Onset Parkinson's Disease Caused by PLA2G6 Compound Heterozygous Mutation, a Case Report and Literature Review

Parkinson’s Disease in Teneurin Transmembrane Protein 4 (TENM4) Mutation Carriers

A Novel Homozygous SYNJ1 Mutation in Two Siblings with Typical Parkinson's Disease.

VPS13C—Another Hint at Mitochondrial Dysfunction in Familial Parkinson's Disease

Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.

Severe Dysphagia as a Presentation of Parkinson’s Disease

LRP10 in Autosomal-Dominant Parkinson's Disease.

A Cysteinyl-tRNA Synthetase Mutation Causes Novel Autosomal-Dominant Inheritance of a Parkinsonism/Spinocerebellar-Ataxia Complex

Current Outlook and Advances in Drug Discovery Approach to Symptomatic Treatment

Parkinson disease: from pathology to molecular disease mechanisms

Autosomal dominant GDAP1 mutation with severe phenotype and respiratory involvement: A case report